Autogenic Training Effects on Pre-eclampsia

Riphah International University

Status: Completed

Conditions: Pre-Eclampsia

Treatments: Other: Autogenic training; Other: Conventional treatment

Study type: Interventional

Funder types: Other

Identifiers

NCT05709834

Adeela

Details and patient eligibility

About

The purpose of study is to find the effects of autogenic training on blood pressure and anxiety in preeclampsia females. There is little of evidence to allow conclusions about effectiveness of autogenic training on preeclampsia Therefore this study will add to the growing body of knowledge that if autogenic training is better than any other protocol for preeclampsia and anxiety then it should be a choice of therapy treatment. This study can provide help pregnant females and other society members to think about treatment of preeclampsia and anxiety other than medical approach.

Full description

Pre-eclampsia is a disorder of pregnancy characterized by the onset of high blood pressure and often a significant amount of protein in the urine. When it arises, the condition mostly begins after 20 weeks of pregnancy. In severe cases of the disease there may be red blood cell breakdown, a low blood platelet count, impaired liver function, kidney dysfunction, swelling, shortness of breath due to fluid in the lungs, or visual disturbances. Pre-eclampsia increases the risk of undesirable outcomes for both the mother and the fetus. Pre-eclampsia affects approximately 2-8% of all pregnancies worldwide. Pre-eclampsia is much more common in women who are pregnant for the first time or have obesity, diabetes and autoimmune disease.

Randomized controlled trial (RCT) will be conducted to find the effects of autogenic training on blood pressure and anxiety in females having pre-eclampsia, the data will be collected from National Hospital and Sofia clinic via sphygmomanometer and DASS-21 scale. Sample size of 26 females is taken. Non probability convenient sampling will be used. A written consent form will be taken from participants meeting inclusion criteria and will be randomly allocated into two groups through lo1.ttery method to either Group A or Group B. Treatment will be given 3 times per week for 4 weeks. Sphygmomanometer will be used to check the blood pressure reading and DASS-21 questionnaire will be used to access anxiety in the females. All participants in both groups will be evaluated before and after the treatment program. Total duration of the study will be ten months. Data will be analyzed by using SPSS 21.

Enrollment: 26 patients

Sex: Female

Ages: 25 to 35 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnose Women with pre-eclampsia
• Blood pressure value more than 90/140
• 2nd trimester
• Age of 25 to 35 years

Exclusion criteria

• Women with cardiorespiratory diseases and diabetes
• Previous history of preterm labor or abortion
• History of serious mental illness

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

26 participants in 2 patient groups

Autogenic training

Experimental group

Description:

It consists of patients who will receive autogenic training and conventional treatment with the frequency of 3 times per week for 4 weeks.

Treatment:

Other: Autogenic training

Control group

Other group

Description:

Its consists of patients who will receive conventional treatment with the frequency of 3 sessions per week

Treatment:

Other: Conventional treatment